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Abstract
Background: Prevention of new HIV infections is a critical public health issue. The highest HIV testing gaps are in
men, adolescents 15–19 years old, and adults 40 years and older. Community-based HIV testing services (HTS) can
contribute to increased testing coverage and early HIV diagnosis, with HIV self-testing (HIVST) strategies showing
promise. Community-based strategies, however, are resource intensive, costly and not widely implemented. A
community-led approach to health interventions involves supporting communities to plan and implement
solutions to improve their health. This trial aims to determine if community-led delivery of HIVST can improve HIV
testing uptake, ART initiation, and broader social outcomes in rural Malawi.
Methods: The trial uses a parallel arm, cluster-randomised design with group village heads (GVH) and their defined
catchment areas randomised (1:1) to community-led HIVST or continue with the standard of the care (SOC). As part
of the intervention, informal community health cadres are supported to plan and implement a seven-day HIVST
campaign linked to HIV treatment and prevention. Approximately 12 months after the initial campaign, intervention
GVHs are randomised to lead a repeat HIVST campaign. The primary outcome includes the proportion of
adolescents 15–19 years old who have tested for HIV in their lifetime. Secondary outcomes include recent testing in
adults 40 years and older and men; ART initiation; knowledge of HIV prevention; and HIV testing stigma. Outcomes
will be measured through cross-sectional surveys and clinic registers. Economic evaluation will determine the cost
per person tested, cost per person diagnosed, and incremental cost effectiveness ratio.
Discussion: To the best of our knowledge, this is the first trial to assess the effectiveness of community-led HTS,
which has only recently been enabled by the introduction of HIVST. Community-led delivery of HIVST is a
promising new strategy for providing periodic HIV testing to support HIV prevention in rural communities. Further,
introduction of HIVST through a community-led framework seems particularly apt, with control over healthcare
concurrently devolved to individuals and communities.
(Continued on next page)
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: peach.indravudh@gmail.com
1Department of Global Health and Development, Faculty of Public Health
and Policy, London School of Hygiene & Tropical Medicine, London, UK
2Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre,
Malawi
Full list of author information is available at the end of the article
Indravudh et al. BMC Infectious Diseases          (2019) 19:814 
https://doi.org/10.1186/s12879-019-4430-4
(Continued from previous page)
Trial registration: Clinicaltrials.gov registry (NCT03541382) registered 30 May 2018.
Keywords: HIV, HIV testing, HIV self-testing, Community-led, Community mobilisation, Adolescents, Men, Malawi
Background
HIV epidemic
Prevention of new HIV infections is a critical public
health issue. In 2017, 1.6 million adults were newly in-
fected with HIV, with two-thirds in sub-Saharan Africa
[1]. Global strategies to reduce HIV incidence aim to
maximise early diagnosis, treatment and viral suppres-
sion of people living with HIV [2]. Regional expansion of
facility-based HIV testing services (HTS) has contributed
to declining HIV incidence, but one-fifth of people with
HIV aged 15–64 years old remain undiagnosed [1].
The highest HIV testing gaps are in men, adolescents
15–19 years old, and adults 40 years and older, con-
tributing to ongoing HIV transmission and poorer
outcomes from late HIV diagnosis [3, 4]. Barriers to
uptake of facility-based HTS include stigmatising
norms, discrimination from health care workers,
distance to health facilities, and direct and indirect
costs of service utilisation [5].
Community-based HIV testing and self-testing
Community-based HTS can contribute to increased
testing coverage, early HIV diagnosis, and reduced HIV
incidence [6–9], with HIV self-testing (HIVST) strat-
egies showing promise [10–12]. In 2016, HIVST was
recommended by WHO as an additional approach to
providing HTS based on evidence of high acceptability,
feasibility, accuracy and uptake [13]. In urban Malawi,
distribution of HIVST kits by community volunteers
achieved high uptake and accuracy, with increased
demand for antiretroviral therapy (ART) with offer of
home-based care [10, 14]. Home-based HIVST in rural
Malawi increased recent testing by 20%, including in
men and adolescents, beyond the percentage achieved
by facility-based HTS [11]. The addition of HIVST kit
distribution to home-based HTS provided by commu-
nity health workers (CHW) in urban Zambia further in-
creased knowledge of status by 3%, with a difference in
intervention effect by sex [12]. Low adverse events were
reported across studies [12, 15].
Community-based strategies, however, are resource in-
tensive, costly and not widely implemented. In population-
based surveys, a low percentage of respondents indicate
most recently testing through community-based services
[16]. Societal costs of community-based HTS and HIVST
tend to be lower than facility-based HTS, but providers
costs are consistently higher, especially the cost per new
HIV diagnosis [7, 17–19].
Community-led approaches to improve health
A community-led approach (also known as community
mobilisation, community-directed or community-driven
approaches) to health interventions involves supporting
communities to develop the knowledge and skills to iden-
tify problems contributing to poor health, plan and imple-
ment solutions to improve their health, and evaluate
implementation of solutions [20, 21].
Most practice uses participatory learning and action
methods, which involve engaging groups of individuals
to identify their needs, understand the root causes of
these needs, and translate awareness into action [22].
From an organisation and service delivery perspective,
community participation in the design and management
of health programmes can enhance their coverage, effi-
ciency and equity through context-driven decision-making
and resource allocation [23]. The change process is based
on a number of assumptions, namely that individuals desire
to be involved in decisions about their own healthcare and
will contribute resources to improve community health;
individuals will be more likely to change their attitudes and
behaviour as a result of their involvement; and individuals
will be empowered through knowledge, skills and confi-
dence gained through their involvement [24, 25].
Evaluations of community-led programmes across mul-
tiple disease areas report evidence of improved health out-
comes at similar or lower cost to vertical programmes,
with applications in onchocerciasis [26], dengue [27–29],
HIV [30, 31], maternal and child health [32–40], and sani-
tation [41, 42]. Within HIV, community-led programmes
have involved outreach events to promote HIV pre-
vention or provision of HTS within multi-disease
campaigns [30, 31, 43]. Most studies also evaluate de-
livery of vertically-defined interventions and disease
areas through community-driven systems, with com-
munity motivation to deliver externally-prescribed
interventions often contingent on the severity of the
perceived risk of disease and value of the intervention
to the health and well-being of the community [44].
Rationale for randomised trial
The types of interventions that can be delivered by com-
munities is expanding with increasing availability of
novel self-care technologies. This trial aims to determine
whether community-led delivery of HIVST can increase
uptake of HIV testing, ART initiation, and broader social
outcomes in a high HIV-burden setting in rural Malawi.
While prior randomised trials have established the
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impact of vertically-delivered, community-based HIVST
models on uptake of HIV testing, it is uncertain whether
similar outcomes could be achieved when increasing
responsibility for the design and management of HIVST
implementation is devolved to communities. In addition
to distribution of kits, HIVST implementation involves
consideration around linkage to routine HIV services and
potential social harm that can be difficult to support in
resource-poor contexts and warrant further evaluation
under a randomised trial.
Methods/design
Aim
The primary aim of this trial is to test whether community-
led delivery of HIVST in rural Malawi can increase the
proportion of the population who has tested for HIV com-
pared to the standard of care (SOC), with a focus on under-
served sub-groups including adolescents 15–19 years old,
older adults 40 years and older, and men. The trial also
aims to assess the impact of community-led HIVST on
ART initiation and broader social outcomes.
Study design
The trial uses a parallel arm, cluster-randomised design
with two stages of randomisation (Fig. 1). Clusters are
defined as group village heads (GVH) and their respect-
ive catchment areas, thereafter referred to as GVHs. The
first stage includes two arms, with 30 GVHs randomised
(1:1) to community-led HIVST or continue with the
SOC. As part of the intervention, community health
action groups and community volunteers plan and im-
plement an HIVST campaign linked to HIV treatment
and prevention services in their areas.
The second stage comprises of a three-arm study with
21 GVHs. Fourteen of 15 GVHs receiving the community-
led HIVST arm in the first stage are randomised (1:1) to
Fig. 1 Flow diagram of trial design
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lead a repeat HIVST campaign approximately 12months
after the initial campaign or not deliver a repeat cam-
paign. Fourteen of 15 GVHs from the SOC arm are
randomised to be included in or excluded from the
second stage of the study.
The trial began in October 2018 and will be completed
in December 2019.
Study setting and population
The trial takes place in the catchment areas of five gov-
ernment health facilities in Mangochi district, which has
among the highest poverty rates and lowest educational
attainment in the country. In 2016, Mangochi had HIV
prevalence of 13.2% in women and 5.7% in men [45].
Coverage of lifetime testing and testing in the last 12
months was, respectively, 70.9 and 36.2% in women and
58.2 and 38.1% in men [45].
Most areas in Malawi are organized by traditional
chieftaincy systems. GVHs have customary authority
over a group of villages, while community health
action groups serve as representatives of community
health issues at GVH-level [46]. Community health
action groups oversee provision of services by village-
level cadres, including village health committees and
community health volunteers. CHWs attached to gov-
ernment health facilities liaise with community health
action groups on delivery of community health
services. In practice, the organisational and operational
capacity of community health structures vary widely.
GVHs were considered eligible for the study if they
were: (i) primarily served by an eligible government health
facility for HIV testing and ART services, (ii) responsible
for an approximate catchment population of at least 2000
people, (iii) sufficiently separated from boundaries of other
intended clusters, and (iv) at least five kilometres away
from an eligible health facility, if possible. All adults aged
15 years and older within GVHs were eligible for the
evaluation. Figure 2 includes a map of Mangochi district,
with health facilities and GVHs included in the trial.
Study procedures
SOC
The SOC is defined based on HIV services currently pro-
vided by the Ministry of Health. In Malawi, HIV testing
and ART services are provided at most health facilities
and through periodic community-based outreach. HIV
testing is administered using finger-prick rapid diagnostic
tests based on the national testing algorithm. Universal
“test-and-treat” guidelines are followed.
Community-led HIVST
The community-led HIVST intervention consists of (i)
participatory workshops for action planning with com-
munity health action groups and CHWs, (ii) trainings on
Fig. 2 Trial clusters in Mangochi district. Map of Mangochi district, Malawi with trial health facilities and group village head-defined clusters. Data
source: data.humdata.org and primary data
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HIVST promotion and support with village-level com-
munity volunteers, and (iii) HIVST campaigns linked to
HIV treatment and prevention (Fig. 3). The framework
for the intervention design is modelled after previous
community mobilisation interventions, which utilise
participatory learning and action methods for critical
reflection and action [22]. The final design was in-
formed by focus group discussions with community
residents, workshops with representatives from the
Department of HIV/AIDS, and piloting prior to the
trial (Additional file 1). The intervention is overseen
by the implementation team, which include the
Malawi-Liverpool-Wellcome Trust Clinical Research
Programme, Population Services International (PSI)
Malawi and the Ministry of Health.
Community health action groups and CHWs attend
two-day participatory workshops. The aim of the work-
shops is to mobilise existing community health struc-
tures and support them in planning and delivering
HIVST campaigns in their catchment areas. As part of
the workshops, community health action groups and
CHWs identify drivers of HIV infection, map available
HIV services and barriers to service utilisation, define
sub-groups underserved by HIV services, and develop a
context-driven campaign. Specifically, they are tasked
with deciding how, when and where HIVST kits will be
delivered and to whom; how self-testers will be supported
to link to routine HIV care and prevention services; what
messages will be delivered alongside HIVST to promote
HIV prevention; how to monitor social harms related to
HIVST; and how to monitor and evaluate the campaign.
Community volunteers also attend two-day trainings
on HIVST promotion and support. Volunteers are
trained in how to provide information and support for
use of HIVST kits, interpretation of results, and linkage
to routine services (confirmatory testing and ART
initiation for reactive results, voluntary medical male cir-
cumcision [VMMC] for men with non-reactive results,
couples testing for serodiscordant partners). Volunteers
also receive training in how to provide information
around HIV prevention, including effectiveness of ART
and VMMC and prevention within serodiscordant part-
ners. Lastly, volunteers are trained in how to anticipate
and respond to social harms, record data, and handle
and store kits.
Community volunteers then implement seven-day
HIVST campaigns linked to HIV treatment and pre-
vention, with supervision by community health action
groups and CHWs. The campaign period is based on the
typical length for HTS campaigns under the Ministry of
Health. The project team provide HIVST kits (OraQuick
HIV Self-Test), informational materials, and data capture
Fig. 3 Intervention design
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tools. Community health action groups and volunteers
receive US$10 gratuity per campaign as nationally stan-
dardised for informal community health cadres. Adults
aged 15 years and older are eligible for HIVST and can
take multiple kits if desired.
Repeat community-led HIVST
Approximately 12 months after the initial HIVST cam-
paign, GVHs allocated to the repeat community-led
HIVST arm will plan and implement an additional cam-
paign, with a similar intervention package provided by
the implementation team.
Outcomes
For the first-stage evaluation, the primary outcome
includes:
 Proportion of adolescents 15–19 years old who have
tested for HIV in their lifetime.
Secondary outcomes include:
 Proportion of older adults 40 years and older who
have tested in the last 3 months.
 Proportion of men who have tested in the last 3
months.
 Cumulative incidence of ART initiation across 6
months.
 Measure of knowledge of HIV prevention methods.
 Measure of perceived HIV testing stigma.
Outcomes will be measured through cross-sectional sur-
veys administered 8–12 weeks after the start of the com-
munity-led HIVST intervention, with matched calendar
time in both study arms. ART initiation will be captured
by clinic assistants stationed at the nearest health facility
for 6 months following the intervention start date.
For the second-stage evaluation, the primary outcome
includes:
 Proportion of individuals who have tested for HIV
in the last 12 months.
Secondary outcomes include:
 Proportion of individuals who have initiated on ART
in the last 12 months.
 Measure of knowledge of HIV prevention methods.
 Measure of perceived HIV testing stigma.
Outcomes will be measured through surveys administered
8–12weeks after the start of the repeat community-led
HIVST intervention.
Sample size
To calculate the sample size for the first-stage evalu-
ation, we assumed that the proportion of lifetime testing
for adolescents aged 15–19 years old in the SOC arm
was 35–50% based on the 2015–16 Malawi Demo-
graphic and Health Survey [45]. With 15 clusters per
arm and 50 adolescents per cluster, we will have at least
90% power to detect a 20% absolute increase in lifetime
testing using a coefficient of variation of outcomes (k) of
0.25. With adolescents making up 20% of the adult
population, this will require 250 respondents per cluster.
For the second-stage evaluation, we assumed testing in
the last 12 months ranged between 30 and 40%. With
seven clusters per arm and 250 respondents per cluster,
we have at least 90% power to detect a 25% absolute dif-
ference in recent testing between the repeat community-
led HIVST and SOC arms, assuming k = 0.25.
Randomisation and blinding
For the main trial, 30 GVHs were randomised 1:1 to
community-led HIVST or SOC. The second stage in-
volves 1:1 randomisation of 14 of the 15 clusters in the
community-led HIVST arm to deliver a repeat or single
HIVST campaign, and 1:1 randomisation of 14 of the 15
clusters in the SOC arm to be included or excluded from
the second-stage evaluation. GVHs were assigned to
study arms at a public ceremony. Three balls numbered
0–9 were selected from an opaque bag, corresponding to
one of 1000 randomisation combinations. Restricted ran-
domisation was used to ensure balance between arms
based on the nearest health facility, distance from the
health facility, population and number of villages. Study
staff are blinded from the study allocation status as
much as possible, with all data managed without
reference to arms.
Data collection
Outcome evaluation
Cross-sectional survey Cross-sectional surveys will be
administered in two rounds approximately 8–10 weeks
after the respective starts of the initial and repeat com-
munity-led HIVST interventions (Fig. 4). For each GVH,
separate evaluation villages for the first and second sur-
vey will be randomly selected from villages with at least
a population of 500 people and located centrally within
the catchment area. All households in the evaluation
villages will be eligible to participate in the survey and
enumerated, with the exception of villages with more
than 250 adults, where 150 households will be enumer-
ated starting with the village head household and
proceeding in a clockwise spiral. Inclusion criteria for
the survey include aged 15 years and older and resident
in eligible households. Written consent will be obtained
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for all participants, except participants aged 15–17 years
old, who will be asked to assent and their parent or
guardian asked to consent (Additional file 2).
All respondents will complete a brief individual question-
naire with modules on sociodemographic characteristics;
prior HIV testing, self-testing, treatment and prevention;
and sexual behaviour. The head of household or represen-
tative will also complete a module on household character-
istics. A random sample of respondents (approximately
20%) will receive an extended questionnaire on community
mobilisation, knowledge of HIV prevention methods, and
HIV testing stigma.
Clinic registers ART initiation will be captured for the
6-month period following the start of the first stage of
the trial. Clinic assistants at the five study health
facilities will establish eligibility of all incoming ART
patients, which include aged 15 years and older, resident
in study clusters, and starting or re-starting on ART.
Sociodemographic characteristics, prior HIVST, and ART
status of eligible patients will be recorded on study forms.
Process evaluation
Quantitative and qualitative data will be collected to
understand implementation and context related to the
community-led HIVST intervention [47]. To investigate
how the intervention was implemented and adaptations
by cluster, data will be collected on the sociodemographic
characteristics of community health action groups and
community volunteers; attendance by community health
action groups and volunteers in workshops, trainings and
HIVST campaigns; and activities planned and implemented
during the campaign. Reach will be assessed using HIVST
registers, which track sociodemographic background and
prior HIV testing of residents collecting HIVST kits.
Reports of linkage to routine HIV services as well as social
harms will also be recorded. Finally, participant observa-
tions and semi-structured interviews will be conducted to
explore how communities perceived and interacted with
the intervention and how the intervention and implementa-
tion were influenced by contextual factors.
Economic evaluation
Financial and economic data will be collected to deter-
mine the cost per person tested and diagnosed under
the community-led HIVST intervention and SOC, and the
incremental cost-effectiveness ratio of the intervention.
Methods are drawn from global guidelines on costing of
health interventions [48]. A societal perspective will be
used to capture costs to providers, communities and indi-
viduals. A combination of ‘top-down’ and ‘bottom-up’
costing approaches will be used, with financial costs from
analysis of expenditures supplemented with full costs ob-
tained through direct observations, individual interviews,
and review of databases and records. Number of tests and
HIV-positive diagnoses will be obtained through extrac-
tion of HTS and HIVST registers.
Data management
Quantitative data will be captured using electronic tab-
lets and optical character recognition forms routinely
entered into a dedicated database. Data will be queried
regularly for errors or inconsistencies and followed-up
according to quality assurance standard operating proce-
dures. Missing data will also be examined by variable
and observation to ascertain the quantity of missing data
and patterns of missingness. Qualitative data will be
recorded using observational notes and digital audio
recordings, which will be transcribed and translated into
English. Study respondents providing written consent
Fig. 4 Trial timeline
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will be assigned an identification number, with names
linked through paper-based recruitment logs stored in
locked filing cabinets.
Statistical analysis
Data analysis for primary and secondary outcomes will
be based on an intention-to-treat using methods appro-
priate for cluster-randomised designs [49]. Covariates,
including but not restricted to sex, age, marital status,
educational attainment and wealth status, will be sum-
marised by study arm to assess for any imbalance. Trial
outcomes will be analysed at a cluster-level, giving each
cluster equal weight. The overall outcome risk for each
cluster will be calculated, and a log transformation will
be applied to the summary value for each cluster if
necessary. The mean and standard deviation of these log
risks will be used to obtain the geometric mean and
associated 95% confidence interval for each study arm.
The risk difference will be calculated for the primary
outcome. The risk ratio, 95% confidence interval and
p-value will also be estimated from t-tests.
Adjusted analysis will use a two-stage approach. Logistic
regression will be used to adjust for confounding bias at
the individual level, and calculate expected events. The ra-
tio of observed to expected events will then be calculated
for each cluster, and log-transformed if appropriate. A t-
test of the log ratio by arm will be used to estimate the
adjusted risk ratio, 95% confidence interval and p-value.
A systematic assessment of missingness will be con-
ducted. Sensitivity analysis will compare complete case
analysis results with those where missing data are im-
puted. A full statistical analysis plan will be developed
prior to unblinding of data.
Results dissemination
The results of this trial will be distributed to global and
national policy makers. Ministry of Health representa-
tives are collaborators on this trial and have advised on
the scope of research to ensure its relevance to national
policy development. Feedback sessions will also be held
with community representatives from participating trial
sites.
Social harms
Social harms will be captured by community health action
groups and community volunteers using programme
registers. Reported social harms will be monitored, cate-
gorised based on an established grading system [50],
followed-up by the project team, and reported to the trial
governance and ethics review committees if appropri-
ate. Social harms will also be assessed through cross-
sectional surveys.
Trial governance, ethics approvals and funding
Oversight of the trial is conducted by an independ-
ent technical advisory group (TAG), which consists
of six public health experts, scientists and policy
makers guiding research under STAR. The TAG
meets semi-annually to review progress, data and
adverse events from ongoing studies. A separate data
and safety monitoring board was not established
given that HIVST is well-established and low risk
[13]. The trial is subject to audits from the London
School of Hygiene & Tropical Medicine (LSHTM)
under their remit as sponsor.
The trial protocol has been approved by research eth-
ics committees at the University of Malawi College of
Medicine (ref: P.01/18/2332), LSHTM (ref: 14761), and
WHO (ref: STAR-comm led CRT-Malawi), with the
latter submission process involving peer review. The trial
is registered with ClinicalTrials.gov (ref: NCT03541382).
Funding is primarily supported by Unitaid, who is
independent of the design, management, analysis and
reporting of the trial.
Discussion
This trial aims to determine if community-led delivery
of HIVST can improve HIV testing uptake, ART initi-
ation, and broader social outcomes in rural Malawi. The
intervention also aims to address current implementa-
tion gaps related to coverage of HIV testing in adoles-
cents 15–19 years, older adults 40 years and older, and
men; resources required for delivering community-based
services; and community engagement in HIV prevention.
To the best of our knowledge, this is the first trial to
assess the effectiveness of community-led HTS, which
has only recently been enabled by the introduction of
HIVST. The trial builds on earlier studies evaluating
‘top-down’ community-based HTS and HIVST [6–12]
and ‘bottom-up’ community-led outreach for HIV pre-
vention [30], which have shown increased uptake of HIV
testing, early detection of people living with HIV, and
reduction in HIV incidence.
The intervention evaluated in this trial consists of
three components implemented across a two-week
period: (i) participatory workshops for action planning,
(ii) trainings on HIVST promotion and support, and (iii)
HIVST campaigns linked to HIV treatment and pre-
vention. Previous evaluations of community-led pro-
grammes have described the importance of the
participatory process [51, 52], which aims to facilitate
dialogue and connection among groups of individuals
towards a collective sense of awareness, solidarity and
agency, and enable groups to take action to address fac-
tors contributing to poor health [53]. We hypothesise
that introduction of HIVST within a community-led
framework could improve access to HIV services and
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health education on HIV testing, treatment and preven-
tion. Potential gains from repeat campaigns will also be
evaluated. Periodicity is an important consideration, with
more frequent implementation potentially lowering costs
but delivering diminishing returns. Further, long-term
community engagement could contribute to improved
community capacity to address their own health prob-
lems as well as influence broader social norms, including
around HIV prevention.
Our intervention aims to facilitate community action
around HIV prevention using HIVST. As part of the inter-
vention, communities are supported to develop strategies
to promote messaging around HIV prevention and linkage
to ART initiation for reactive results, VMMC for men
with non-reactive results, and couples testing for serodis-
cordant partners. Linking HIVST with HIV prevention
strategies is critical for maximising the health impact of
HIV testing, especially with declining HIV positivity. At
the same time, HIVST could be used to generate de-
mand for HIV prevention at individual and community
levels [54].
This trial will provide evidence on an alternative model
for community-based HTS that could be adopted in
settings with established community health structures.
Underlying this trial is the question of whether informal
community health cadres in rural sub-Saharan Africa can
effectively lead the design and management of HIVST
implementation. Provision of HIVST involves multiple
components, including distribution of kits, education on
correct use of kits, support for linkage to routine HIV ser-
vices, safety monitoring, and data capture and assessment.
At best, shifting responsibility for HIVST implementation
to communities could result in the aforementioned health
and social benefits and cost reductions. At worst, mis-
diagnosis, loss to follow-up and social harm could arise
from poor-quality implementation, compromising gains
in health. The burden of implementation could place
further economic costs on resource-constrained com-
munities [26, 55]. Elite capture, whereby socially and
economically privileged sub-groups are favoured in re-
source allocation, could also perpetuate existing health
disparities [56].
This trial has a number of anticipated limitations.
First, the SOC arm is defined by the standard HTS
package provided by the Ministry of Health, which
includes facility-based HTS and recurring commu-
nity-based outreach, rather than parallel community-
based HTS or HIVST campaigns. As a result, the
effect of the community-led and HIVST intervention
components may be difficult to isolate. Second, trial
outcomes cannot be adjusted for cluster-level differ-
ences between arms at baseline since data were not
collected prior to implementation. Third, we anticipate
wide cluster-level adaptation of implementation, with our
process data critical to understanding any outcome
variation.
In summary, the primary aim of this trial is to test
whether community-led delivery of HIVST in rural
Malawi can increase the proportion of the population
who has tested for HIV compared to the SOC, with a
focus on underserved sub-groups. The trial also aims to
assess the impact of community-led HIVST on ART
initiation and broader social outcomes. Community-led
HIVST is a promising new strategy for providing periodic
HIV testing to support HIV prevention in rural communi-
ties. Further, introduction of HIVST through a commu-
nity-led framework seems particularly apt, with control
over healthcare concurrently devolved to individuals and
communities.
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